Aldeyra Therapeutics
NASDAQ: ALDXLexington, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
TC
Todd C. BradyExecutive Officer, Director
BB
Ben BronsteinDirector
ST
Stephen TulipanoExecutive Officer
GP
Gary PhillipsDirector
NW
Neal WalkerDirector
JI
Jesse I. TreuDirector
SL
Scott L. YoungExecutive Officer
MJ
Martin J. JoyceDirector
CB
C. Boyd ClarkeDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$10MraisedFeb 2019 · 37 investors · BiotechnologyRule 506(b)
▶$10MraisedFeb 2019 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard DouglasDirector
- Neal WalkerDirector
- Martin J. JoyceDirector
- Jesse I. TreuDirector
- Todd BradyExecutive Officer, Director
- David L. ClarkExecutive Officer
- Ben BronsteinDirector
- David McMullinExecutive Officer
- Gary PhillipsDirector
- Stephen MachathaExecutive Officer
- Joshua ReedExecutive Officer
- Offering amount
- $25M
- Amount sold
- $10M
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedFeb 2015 · 1 investors · BiotechnologyRule 506(b)
▶$2MraisedFeb 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jesse I. TreuDirector
- Neal WalkerDirector
- Stephen TulipanoExecutive Officer
- Scott YoungExecutive Officer
- C.Boyd ClarkeDirector
- Ben BronsteinDirector
- Martin J. JoyceDirector
- Gary PhillipsDirector
- Todd C. BradyExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $2M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.8MraisedJan 2015 · 16 investors · BiotechnologyRule 506(b)
▶$7.8MraisedJan 2015 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Todd C. BradyExecutive Officer, Director
- Ben BronsteinDirector
- Stephen TulipanoExecutive Officer
- Gary PhillipsDirector
- Neal WalkerDirector
- Jesse I. TreuDirector
- Scott L. YoungExecutive Officer
- Martin J. JoyceDirector
- C. Boyd ClarkeDirector
- Offering amount
- $18.4M
- Amount sold
- $7.8M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.